FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

695711000001101: Glibenclamide 5mg tablets (Alpharma Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16680501000001119 Glibenclamide 5mg tablets (Alpharma Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
37817201000001111 Glibenclamide 5mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glibenclamide 5mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Is a Product containing precisely glibenclamide 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has active ingredient Glibenclamide false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has active ingredient Glyburide false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has active ingredient Glibenclamide false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has specific active ingredient Glibenclamide true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Glibenclamide 5mg tablets (Alpharma Limited) 28 tablet 2 x 14 tablets Is pack of False Glibenclamide 5mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier
Glibenclamide 5mg tablets (Alpharma Limited) 28 tablet 2 x 14 tablets Has AMP True Glibenclamide 5mg tablets (Alpharma Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start